3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dystonia

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Dystonia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beukers, RJ; Booij, J; Tijssen, MA; van Amelsvoort, TA; Weisscher, N; Zijlstra, F	1
Hwang, WJ; Ting, G; Wey, SP; Yao, WJ	1
Berding, G; Dengler, R; Gratz, KF; Hundeshagen, H; Knoop, BO; Kolbe, H; Meyer, GJ	1

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dystonia

Article	Year
123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia. Nuklearmedizin. Nuclear medicine, 1994, Volume: 33, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Corpus Striatum; Dopamine Antagonists; Dystonia; Frontal Lobe; Humans; Iodine Radioisotopes; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	1994

Article

Year

123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.

Nuklearmedizin. Nuclear medicine, 1994, Volume: 33, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Benzamides; Corpus Striatum; Dopamine Antagonists; Dystonia; Frontal Lobe; Humans; Iodine Radioisotopes; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1994

Other Studies

2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dystonia

Article	Year
Reduced striatal D2 receptor binding in myoclonus-dystonia. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:2 Topics: Adult; Aged; Benzamides; Case-Control Studies; Dystonia; Female; Humans; Male; Middle Aged; Mutation; Myoclonus; Neostriatum; Occipital Lobe; Protein Binding; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	2009
Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia. European neurology, 2004, Volume: 51, Issue:1 Topics: Adult; Benzamides; Brain; Contrast Media; Diagnosis, Differential; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes	2004

Article

Year

Reduced striatal D2 receptor binding in myoclonus-dystonia.

European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:2

Topics: Adult; Aged; Benzamides; Case-Control Studies; Dystonia; Female; Humans; Male; Middle Aged; Mutation; Myoclonus; Neostriatum; Occipital Lobe; Protein Binding; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

2009

Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.

European neurology, 2004, Volume: 51, Issue:1

Topics: Adult; Benzamides; Brain; Contrast Media; Diagnosis, Differential; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes

2004